Preparation group |
P* | ||||
---|---|---|---|---|---|
4L PEG (n=134) | 2L PEG + B (n=136) | NaP (n=100) | PSMC + M (n=121) | ||
Right colon | 1.49 | 1.17 | 2.38 | 1.58 | <0.0001† |
Middle colon | 1.00 | 0.87 | 1.37 | 1.02 | 0.002‡ |
Rectosigmoid colon | 1.09 | 0.94 | 1.30 | 0.80 | 0.004§ |
Overall fluid | 0.56 | 0.56 | 0.33 | 0.46 | 0.12 |
Total score (95%CI) | 4.14 (3.63–4.64) | 3.51 (3.06–3.96) | 5.37 (4.80–5.94) | 3.84 (3.35–4.34) | <0.0001¶ |
Corrected for multiple comparisons;
Significant difference between NaP and 4L PEG, between NaP and 2L PEG+B, and between NaP and PSMC;
Significant difference between NaP and 4L PEG, between NaP and 2L PEG + B, and between NaP and PSMC;
Significant difference between NaP and 4L PEG, between NaP and 2L PEG + B, and between NaP and PSMC.
Significant difference between NaP and 4L PEG, between NaP and 2L PEG + B, and between NaP and PSMC. B Bisacodyl; M Magnesium citrate; NaP Sodium phosphate; PEG Polyethylene glycol; PSMC Pico-Salax (Ferring Pharmaceuticals Inc, Canada)